LAUSR

Hillmen, P., Hallek, M. & Buske, C. (2015) Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 26, 78–84. Hallek, M., Cheson, B.D., Catovsky, D., CaligarisCappio, F., Dighiero, G., Dohner, H., Hillmen, P., Keating, M.J., Montserrat, E., Rai, K.R. & Kipps, T.J. (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood, 111, 5446–5456. Huang, Y., Kumazoe, M., Bae, J., Yamada, S., Takai, M., Hidaka, S., Yamashita, S., Kim, Y., Won, Y., Murata, M., Tsukamoto, S. & Tachibana, H. (2015) Green tea polyphenol epigallocatechin-O-gallate induces cell death by acid sphingomyelinase activation in chronic myeloid leukemia cells. Oncology Reports, 34, 1162–1168. Kumazoe, M., Kim, Y., Bae, J., Takai, M., Murata, M., Suemasu, Y., Sugihara, K., Yamashita, S., Tsukamoto, S., Huang, Y., Nakahara, K., Yamada, K. & Tachibana, H. (2013) Phosphodiesterase 5 inhibitor acts as a potent agent sensitizing acute myeloid leukemia cells to 67-kDa laminin receptor-dependent apoptosis. FEBS Letters, 587, 3052–3057. Kumazoe, M., Tsukamoto, S., Lesnick, C., Kay, N.E., Yamada, K., Shanafelt, T.D. & Tachibana, H. (2015) Vardenafil, a clinically available phosphodiesterase inhibitor, potentiates the killing effect of EGCG on CLL cells. British Journal of Haematology, 168, 610–613. Oscier, D., Dearden, C., Eren, E., Fegan, C., Follows, G., Hillmen, P., Illidge, T., Matutes, E., Milligan, D.W., Pettitt, A., Schuh, A. & Wimperis, J. (2012) Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia. British Journal of Haematology, 159, 541–564. Shanafelt, T.D., Call, T.G., Zent, C.S., Leis, J.F., LaPlant, B., Bowen, D.A., Roos, M., Laumann, K., Ghosh, A.K., Lesnick, C., Lee, M.J., Yang, C.S., Jelinek, D.F., Erlichman, C. & Kay, N.E. (2013) Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia. Cancer, 119, 363–370. Tsukamoto, S., Yamashita, S., Kim, Y.H., Kumazoe, M., Huang, Y., Yamada, K. & Tachibana, H. (2012) Oxygen partial pressure modulates 67-kDa laminin receptor expression, leading to altered activity of the green tea polyphenol, EGCG. FEBS Letters, 586, 3441–3447.